Skip to main content

Table 1 Primers and restriction enzymes used for the analysis of VEGF polymorphisms

From: Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

Primers Restriction enzyme Reference SNP
VEGF -1498 C/T
F:5'-TGT GCG TGT GGG GTT GAG CG
R:5'-TAC GTG CGG ACA GGG CCT GA
BstUI rs833061
VEGF + 405 C/G
F:5'-ATT TAT TTT TGC TTG CCA TT
R:5'-GTC TGT CTG TCT GTC CGT CA
BsmFI rs2010963
VEGF -2578 C/A
F:5'-GGC CTT AGG ACA CCA TAC C
R:5'-CAC AGC TTC TCC CCT ATC C
BstYI rs699947
VEGF + 936 C/T
F:5'-AAG GAA GAG GAG ACT CTG CGC AGA GC
R:5'-TAA ATG TAT GTA TGT GGG TGG GTG TGT CAT CAG G
NlaIII rs3025039